Last updated 2026-06-18
- Went public on NASDAQ, Aug 2019
- Acquired Viveve Medical, Jul 2023
Total raised
$70.0M
Stage
Public
Founded
2008
Headcount
500+
HQ
Yokne'am Illit, Israel
Sector
Health Tech & Life Sciences
About
InMode is a global provider of energy-based minimally invasive and noninvasive aesthetic solutions. The company has developed and commercialized products utilizing medically accepted radio-frequency (RF) energy technology, which can penetrate deep into the subdermal fat layer to allow adipose tissue remodeling.
The company's technologies are used by physicians to remodel subdermal adipose, or fatty tissue, through a variety of procedures, including liposuction with simultaneous skin tightening, face and body contouring, and ablative skin rejuvenation treatments.
InMode offers effective medical aesthetic solutions with BodyTite, Optimas, Votiva, Contoura, EmbraceRF, Evoke, Evolve, and Triton workstations.
Q&A
- What is InMode's primary business?
- InMode is a global provider of energy-based minimally invasive and noninvasive aesthetic solutions, utilizing medically accepted radio-frequency (RF) energy technology for procedures such as liposuction with skin tightening, face and body contouring, and ablative skin rejuvenation treatments.
- When did InMode go public and on which exchange?
- InMode went public on NASDAQ in August 2019, raising $70 million with a valuation of $450 million.
- What was a significant acquisition made by InMode recently?
- InMode acquired Viveve Medical in July 2023.
- What was InMode's reported revenue for the first quarter of 2026?
- InMode reported a GAAP revenue of $82 million for the first quarter of 2026, representing a 5% year-over-year increase.
- What was InMode's revenue guidance for the third quarter of 2025?
- InMode expected third quarter 2025 revenue to be between $92.5 million and $93.0 million.
- What leadership changes did InMode announce in May 2026?
- InMode appointed Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer in May 2026.
- What action did InMode take regarding its shares in September 2024?
- InMode announced a share repurchase program of up to 7.68 million shares in September 2024.
- What was a key product development announced by InMode in July 2024?
- InMode introduced IgniteRF, a complete minimally invasive soft tissue contraction platform, in July 2024.
- What was the outcome of InMode's board review of acquisition proposals in February 2026?
- In February 2026, InMode's board announced that none of the acquisition proposals received were deemed suitable.
- What was InMode's revenue guidance for the full year 2026?
- InMode reiterated its full-year 2026 revenue guidance to be between $365 million and $375 million.
Team · 1
Moshe Mizrahy
Founder · Co-founder & CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
B2B
Highlights
Patents
Tags
rf-technologyclinicsnon-surgicalnon-invasiveskin-caremedical-devicesdermatologyminimally-invasivedoctorsmedical-technologieslaserswellnessaesthetic-devicesbody-contouringwomen's-healthplastic-surgerygynecologyotolaryngologyophthalmologypublicly-tradedmedical-aestheticsradio-frequencyskin-tighteningmedspas
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | inmodemd.com |
|---|---|
| linkedin.com/company/5279219 | |
| X / Twitter | twitter.com/inmodesolutions |
Identifiers & details
| Legal name | InMode Ltd. |
|---|---|
| Founded | 2008-1 |
| Employees (exact) | 660 |
Acquisitions & public offerings
| Acquired | Date | Amount |
|---|---|---|
| Viveve Medical | 2023-07 |
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| 2019-08 | NASDAQ | $70.0M |